endometrial ablation
Sponsors
Agency for Healthcare Research and Quality (AHRQ), Duke University, Quintiles, Inc., Naser Al-Husban, Centre Hospitalier Universitaire de Nīmes
Conditions
AdenomyosisEndometriosisFibroids, UterineMenorrhagiaPrognostic FactorsTreatment FailuresUterine BleedingUterine Fibroids
Phase 3
Unknown Phase
Patient Centered Results for Uterine Fibroids
CompletedNCT02260752
Start: 2015-11-30End: 2020-04-30Updated: 2020-11-18
Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids
CompletedNCT02819609
Start: 2014-11-30End: 2015-01-31Updated: 2016-06-30
Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection
CompletedNCT05483348
Start: 2022-02-17End: 2022-04-28Updated: 2022-08-02
Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay
RecruitingNCT06864494
Start: 2025-06-25End: 2027-06-01Target: 60Updated: 2026-03-18